Study of the effects of Prolonged-Release Torasemide on myocardial fibrosis in hypertensive patients with chronic heart failure: design and baseline characteristics

被引：0
|
作者：
Gonzalez Juanatey, J. R. [1 ]
Anguita, M. [2 ]
Coca, A. [3 ]
De Teresa, E. [4 ]
Diez, J. [5 ]
Fernandez, E. [6 ]
Castro Beiras, A. [7 ]
机构：
[1] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela, Spain
[2] Hosp Univ Reina Sofia, Cordoba, Spain
[3] Hosp Clin Univ Barcelona, Barcelona, Spain
[4] Hosp Virgen Victoria, Malaga, Spain
[5] Ctr Invest Med Aplicada, Pamplona, Spain
[6] Novag Ferrer Int, Barcelona, Spain
[7] Univ A Coruna, La Coruna, Spain
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：720 / 720
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF PROLONGED-RELEASE TORASEMIDE ON MYOCARDIAL FIBROSIS IN PATIENTS WITH CHRONIC HEART FAILURE: DESIGN AND BASELINE CHARACTERISTICS
    Coca, A.
    De Teresa, E.
    Castro Beiras, A.
    Anguita, M.
    Fernandez, E.
    Diez, J.
    JOURNAL OF HYPERTENSION, 2009, 27 : S61 - S61
  • [2] Effects of Prolonged-Release Torasemide Versus Furosemide on Myocardial Fibrosis in Hypertensive Patients with Chronic Heart Failure: A Randomized, Blinded End Point, Active-Controlled Study
    Anguita, M.
    Castro Beiras, A.
    Cobo, E.
    Coca, A.
    De Teresa, E.
    Diez, J.
    Lopez, B.
    Cebollada, J.
    Diaz, B.
    Galve, E.
    Gonzalez-Juanatey, J. R.
    Jimenez-Navarro, M.
    Lopez, I.
    Lupon, J.
    Martin, C.
    Monserrat, L.
    Narejos, S.
    Pascual Figal, D. A.
    Perez-Calvo, J. I.
    Querejeta, R.
    Ridocci, F.
    Rodriguez, A.
    Rodriguez, M.
    Roig, E.
    Roure, J.
    Ruiz, S.
    Sanchez, P. L.
    Terns, M.
    Toran, P.
    Munoz-Tuduri, Marta
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1204 - 1213
  • [3] The Effects of Torasemide on Patients with Chronic Heart Failure
    Alyavi, Bakhrom
    Mukhamedova, Muyassar
    Arnopolskaya, Dina
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2013, 3 (01) : 20 - 22
  • [4] Torasemide but not furosemide improves myocardial remodeling in patients with chronic heart failure
    López, B
    Sánchez, E
    González, A
    Querejeta, R
    Larman, M
    Querejeta, R
    Larman, M
    Díez, J
    CIRCULATION, 2003, 108 (17) : 342 - 342
  • [5] Ways of Optimizing Diuretic Therapy in Chronic Congestive Heart Failure, - Place of Torasemide Prolonged Release
    Kobalava, Zh. D.
    Kiyakbaev, G. K.
    KARDIOLOGIYA, 2014, 54 (04) : 69 - +
  • [6] Biochemical monitoring of myocardial fibrosis in hypertensive patients with heart failure
    López, B
    González, A
    Querejeta, R
    Larman, M
    Sánchez, E
    Ubago, JLM
    Díez, J
    JOURNAL OF HYPERTENSION, 2003, 21 : S7 - S8
  • [7] Biochemical monitoring of myocardial fibrosis in hypertensive patients with heart failure
    López, B
    González, A
    Querejeta, R
    Larman, M
    Sánchez, E
    Ubago, JLM
    Díez, J
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 15A - 15A
  • [8] Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure
    Yamato, M
    Sasaki, T
    Honda, K
    Fukuda, M
    Akutagawa, O
    Okamoto, M
    Hayashi, T
    CIRCULATION JOURNAL, 2003, 67 (05) : 384 - 390
  • [9] Association of Cardiotrophin-1 With Myocardial Fibrosis in Hypertensive Patients With Heart Failure
    Lopez, Begona
    Gonzalez, Arantxa
    Querejeta, Ramon
    Larman, Mariano
    Rabago, Gregorio
    Diez, Javier
    HYPERTENSION, 2014, 63 (03) : 483 - 489
  • [10] Lack of association of galectin-3 with myocardial fibrosis in patients with chronic stable heart failure of hypertensive origin
    Lopez Salazar, B.
    Gonzalez Miqueo, A.
    Querejeta Iraola, R.
    Larman Tellechea, M.
    Diez Martinez, J.
    CARDIOVASCULAR RESEARCH, 2014, 103
12345